Diabetes in elderly adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 1, 2001, Pages M5-M13

  Meneilly, G S ^a   Tessier, D ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; ELDERLY CARE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADULT; AGED; ALPHA-GLUCOSIDASES; DIABETES MELLITUS, TYPE 2; DIET THERAPY; EXERCISE; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; RISK FACTORS; THIAZOLES; THIAZOLIDINEDIONES; UNITED STATES;

EID: 0035160241     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.1.M5     Document Type: Review

References (67)

1. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults
2. Undiagnosed NIDDM: Clinical and public health issues
3. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes
4. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus
5. Diabetes in the elderly
6. Lilly Lecture 1987. The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM
7. NIDDM in the elderly
8. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects
9. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes
10. Diabetes mellitus: A major disease of older persons
11. Relation between plasma tumor necrosis factor alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus
12. Role of glucose effectiveness in the determination of glucose tolerance
13. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes
14. Insulin, nitric oxide and the sympathetic nervous system: At the crossroads of metabolic and cardiovascular regulation
15. Insulin-mediated increase in blood is impaired in the elderly
16. GAD antibodies in elderly men in different categories of glucose tolerance
17. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes
18. Significance of GAD positivity in elderly patients with diabetes
19. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993
20. Mortality in older people with diabetes mellitus
21. Fasting plasma glucose variability predicts 10 year survival of type 2 diabetic patients
22. Relationship between blood glucose level and mortality type 2 diabetes mellitus: A systematic review
23. The contribution of chronic conditions and disabilities to poor self-rated health in elderly men
24. Comorbidity of five chronic health conditions in elderly community residents: Determinants and impact on mortality
25. Self-reported prevalence and health correlates of functional limitation among Massachusetts elderly Puerto Ricans, Dominicans, and a non-Hispanic white neighborhood comparison group
26. Reported and measured physical functioning in older diabetic African Americans
27. Drug-induced hypoglycemic coma in 102 diabetic patients
28. Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes
29. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin
30. Safety of human insulin in poor sighted elderly diabetic patients
31. Transferring aged type 1 diabetic patients from animal to human insulin: A randomised study
32. Hospitalization and mortality of diabetes in older adults
33. Diabetes and dementia in long-term care
34. Report of the expert committee on the diagnosis and classification of diabetes mellitus
35. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the US population
36. Diabetes in older adults: Comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification
37. Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria
38. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men
39. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
40. Model of complications of NIDDM. I
41. Model of complications of NIDDM. II
42. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
43. Benefit and cost analysis in geriatric care
44. Antidiabetic treatment trends in a cohort of elderly people with diabetes
45. Glycemic control of older adults with type 2 diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994
46. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
47. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
48. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
49. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
50. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients
51. Effects of an oral glucose challenge on free radicals/antioxidants balance in an older population with type 2 diabetes
52. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients
53. Effect of acarbose on insulin sensitivity in elderly patients with diabetes
54. Poorly controlled elderly type 2 diabetic patients: The effects of increasing sulphonylurea dosages or adding metformin
55. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients
56. A study of the effect of age on the pharmacokinetics of BRL 49653C in healthy volunteers
57. Rosiglitazone is effective and well tolerated in patients over 65 years with type 2 diabetes
58. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose
59. A comparison of premixed insulin preparations in elderly patients
60. Combination of insulin and glibenclamide in the treatment of elderly non insulin-dependent (type 2) diabetic patients
61. Comparison of different insulin regimens in elderly patients with NIDDM
62. Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes
63. Efficacy of repaglinide in elderly vs younger patients with type 2 diabetes: HbA1c and FPG parameters in long-term trials
64. A study of fluoxetine in obese elderly patients with type 2 diabetes
65. Role of orlistat in the treatment of obese patients with type 2 diabetes
66. Clinical evaluation of serum fructosamine in monitoring elderly outpatient diabetics
67. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects